A important advancement in glucose management is emerging with the approval of tirzepatide at a dosage of 45mg. This new version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://arunffyk237748.wikipublicity.com/8467440/revolutionary_introduction_tirzepatide_dose_for_glucose_regulation